Clinical Trials Logo
  1. Home
  2. Infertility
  3. NCT01820728
  4. Details
NCT01820728 Clinical Trial

A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Infertility Clinical Trial

Official title:
A Phase III Clinical Study for the Comparison Evaluation of DA-3801 and Gonal-F® in Infertile Female Patients With Chronic Anovulation Syndrome

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01820728
Other study ID # DA3801_CA_III (Version 5.1)
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date January 2007
Est. completion date October 2012

Study information
Verified date April 2021
Source Dong-A ST Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

open label, active-controlled, randomized, parallel group, comparative study.

Description:

This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene citrate treatment. The study is conducted with following methods: open label, active-controlled, randomized, parallel group, comparative.

Recruitment information / eligibility
Status Completed
Enrollment 93
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 38 Years
Eligibility Inclusion Criteria: - WHO group II - Clomiphene citrate resistance - BMI: 17~29 kg/m^2 - Irregular menstrual cycle - Normal blood concentration of FSH, E2, prolactin and TSH Exclusion Criteria: - Uncontrolled endocrine disease - Ovarian cystic tumor which are NOT related to PCOS - Severe endometriosis - Chronic cardiovascular disease, liver complaint

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• DA-3801 Injection

• Gonal-F®

Locations
Country Name City State
Korea, Republic of Seoul National University Hospital Institutional Review Board Seoul

Sponsors (1)
Lead Sponsor Collaborator
Dong-A ST Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary The ovulation rate after 3 cycles of the injection 5 weeks maximum
Secondary Total dose used, IU (International Unit) 5 weeks
Secondary Duration of stimulation, days 5 weeks
Secondary Threshold dose, IU 5 weeks
Secondary Number of follicles Counter the number of follicles which are 12 mm, 15 mm, 18 mm in diameter 5 weeks
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A